Advisornet Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.68M | Sell |
9,327
-219
| -2% | -$105K | 0.21% | 95 |
|
|
2026
Q1 | $4.69M | Sell |
9,546
-32
| -0.3% | -$17.4K | 0.24% | 86 |
|
|
2025
Q4 | $5.55M | Buy |
9,578
+24
| +0.3% | +$13.6K | 0.3% | 74 |
|
|
2025
Q3 | $4.63M | Sell |
9,554
-20
| -0.2% | -$9.31K | 0.26% | 79 |
|
|
2025
Q2 | $3.88M | Sell |
9,574
-151
| -2% | -$63.1K | 0.25% | 81 |
|
|
2025
Q1 | $4.84M | Sell |
9,725
-63
| -0.6% | -$34.1K | 0.36% | 60 |
|
|
2024
Q4 | $5.09M | Sell |
9,788
-1,182
| -11% | -$650K | 0.43% | 53 |
|
|
2024
Q3 | $6.79M | Sell |
10,970
-180
| -2% | -$107K | 0.51% | 39 |
|
|
2024
Q2 | $6.17M | Buy |
11,150
+21
| +0.2% | +$12K | 0.56% | 34 |
|
|
2024
Q1 | $6.47M | Sell |
11,129
-406
| -4% | -$228K | 0.62% | 31 |
|
|
2023
Q4 | $6.12M | Buy |
11,535
+307
| +3% | +$149K | 0.56% | 31 |
|
|
2023
Q3 | $5.68M | Buy |
11,228
+41
| +0.4% | +$21.8K | 0.52% | 42 |
|
|
2023
Q2 | $5.84M | Buy |
11,187
+53
| +0.5% | +$28.6K | 0.5% | 41 |
|
|
2023
Q1 | $6.42M | Buy |
11,134
+92
| +0.8% | +$51.9K | 0.59% | 38 |
|
|
2022
Q4 | $6.08M | Buy |
11,042
+3
| +0% | +$1.59K | 0.6% | 39 |
|
|
2022
Q3 | $5.6M | Buy |
11,039
+159
| +1% | +$89K | 0.56% | 41 |
|
|
2022
Q2 | $5.91M | Buy |
10,880
+326
| +3% | +$179K | 0.58% | 36 |
|
|
2022
Q1 | $6.23M | Buy |
10,554
+2,267
| +27% | +$1.3M | 0.39% | 52 |
|
|
2021
Q4 | $5.53M | Sell |
8,287
-97
| -1% | -$60.6K | 0.34% | 68 |
|
|
2021
Q3 | $4.79M | Sell |
8,384
-5,870
| -41% | -$3.22M | 0.33% | 67 |
|
|
2021
Q2 | $7.19M | Buy |
14,254
+101
| +0.7% | +$47.7K | 0.48% | 44 |
|
|
2021
Q1 | $6.46M | Buy |
14,153
+186
| +1% | +$88.8K | 0.46% | 46 |
|
|
2020
Q4 | $6.5M | Sell |
13,967
-240
| -2% | -$113K | 0.53% | 37 |
|
|
2020
Q3 | $6.27M | Sell |
14,207
-129
| -0.9% | -$53.3K | 0.54% | 34 |
|
|
2020
Q2 | $5.19M | Sell |
14,336
-855
| -6% | -$287K | 0.42% | 51 |
|
|
2020
Q1 | $4.31M | Buy |
15,191
+5,582
| +58% | +$1.76M | 0.4% | 58 |
|
|
2019
Q4 | $3.12M | Sell |
9,609
-118
| -1% | -$35.8K | 0.26% | 84 |
|
|
2019
Q3 | $2.83M | Sell |
9,727
-394
| -4% | -$113K | 0.26% | 90 |
|
|
2019
Q2 | $2.97M | Sell |
10,121
-331
| -3% | -$91.2K | 0.33% | 68 |
|
|
2019
Q1 | $2.86M | Sell |
10,452
-3
| -0% | -$747 | 0.35% | 64 |
|
|
2018
Q4 | $2.34M | Sell |
10,455
-45
| -0.4% | -$10.6K | 0.32% | 68 |
|
|
2018
Q3 | $2.56M | Sell |
10,500
-152
| -1% | -$35K | 0.32% | 65 |
|
|
2018
Q2 | $2.21M | Sell |
10,652
-6
| -0.1% | -$1.27K | 0.3% | 68 |
|
|
2018
Q1 | $2.2M | Sell |
10,658
-210
| -2% | -$44.1K | 0.3% | 69 |
|
|
2017
Q4 | $2.06M | Buy |
+10,868
| New | +$2.08M | 0.31% | 68 |
|
Other funds holding TMO
Advisornet Financial's TMO Position: Q2 2026 in Review
Advisornet Financial reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q2 2026, selling an estimated $105K and leaving 9,327 shares worth $4.68M. The position accounts for 0.21% of the portfolio, ranked #95.
Advisornet Financial first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.19M in Q2 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Advisornet Financial held 9,327 shares of Thermo Fisher Scientific worth $4.68M as of Q2 2026.
- Advisornet Financial sold 219 Thermo Fisher Scientific shares in Q2 2026, an estimated $105K.
- Thermo Fisher Scientific made up 0.21% of Advisornet Financial's portfolio in Q2 2026, its #95 holding.
- Advisornet Financial first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Thermo Fisher Scientific position peaked at $7.19M in Q2 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.